Visceral organ protection in aortic arch surgery: safety of moderate hypothermia
Autor: | Davide Pacini, Antonio Pantaleo, Luca Di Marco, Alessandro Leone, Roberto Di Bartolomeo, Giuseppe Barberio, Sebastiano Castrovinci, S. Sottili, Giacomo Murana |
---|---|
Přispěvatelé: | Pacini, Davide, Pantaleo, Antonio, di Marco, Luca, Leone, Alessandro, Barberio, Giuseppe, Murana, Giacomo, Castrovinci, Sebastiano, Sottili, Sandra, di Bartolomeo, Roberto |
Rok vydání: | 2014 |
Předmět: |
Aortic arch
Male Kidney Disease Time Factors medicine.medical_treatment Aorta Thoracic Hypothermia law.invention Aortic aneurysm law Hypothermia Induced Risk Factors Cardiac Surgical Procedure Cerebral protection Cardiopulmonary Bypass Cardiopulmonary Bypa Liver Disease Medicine (all) Liver Diseases General Medicine Middle Aged Aortic Aneurysm Anesthesia Cardiology Female Kidney Diseases Hemodialysis medicine.symptom Cardiology and Cardiovascular Medicine Human Pulmonary and Respiratory Medicine medicine.medical_specialty Time Factor Visceral protection Preoperative care Reperfusion therapy Internal medicine medicine.artery medicine Cardiopulmonary bypass Humans Cardiac Surgical Procedures Dialysis Aged business.industry Risk Factor Biomarker Aortic arch repair medicine.disease Surgery business Biomarkers |
Zdroj: | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 46(3) |
ISSN: | 1873-734X |
Popis: | Objectives: Although antegrade selective cerebral perfusion (ASCP) provides good brain protection during aortic arch surgery, the issue of distal organ protection during circulatory arrest remains to be clarified. The aim of the study was to retrospectively evaluate the outcome of aortic arch surgery using ASCP at different temperatures, focusing on visceral functions (VFs). Methods: Three hundred and thirty-four patients underwent elective aortic arch surgery using ASCP from November 1996 to March 2011. Those patients without early postoperative low cardiac output syndrome were included. VFs were evaluated by comparing preoperative and postoperative creatinine, aspartate amino transferase, alanine amino transferase and bilirubin. Univariate and multivariate analysis were performed. Results: Three hundred and four patients represent the cohort of the study. Deeper systemic hypothermia (â¤25°C) (Group A) was used in 194 patients (63.8%) and moderate hypothermia (>25°C) (Group B) in 110 patients (36.2%). The 30-day mortality rate was 3.6% in Group B and 5.2% in Group A (P = NS). Permanent neurological deficits occurred in 4 (3.6%) and in 14 patients (7.2%) of Group A and Group B, respectively (P = NS). Postoperative renal insufficiency requiring dialysis occurred in 6 patients (5.4%) in Group A and in 15 patients (7.7%) in Group B, the differences were not statistically significant. Biochemical markers of VFs increased in the postoperative period without differences between groups. At the multivariate analysis, cardiopulmonary bypass time >180 min (odds ratio (OR) = 2.16) was the only significant risk factor for renal dysfunction with or without liver dysfunction, while cardiopulmonary bypass time longer than 180min (OR = 2.28) and hypothermia higher than 25°C (OR = 0.54) were found to be independently related to liver dysfunction. Conclusions: Our results confirmed that ASCP with moderate hypothermia at 26°C is a safe method for brain protection. Moreover, during circulatory arrest, moderate hypothermia also offers good protection of visceral organs and it should be preferred for limited periods ( |
Databáze: | OpenAIRE |
Externí odkaz: |